Upgrade to SI Premium - Free Trial

H.C. Wainwright Upgrades Arcus Biosciences (RCUS) to Buy

February 26, 2025 6:06 AM
H.C. Wainwright analyst Emily Bodnar upgraded Arcus Biosciences (NYSE: RCUS) from Neutral to Buy with a price target of $24.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Upgrades

Next Articles